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 While evidence-based medicine has its origins well before the 19th century, it was not 
until the beginning of the 1990s that it began dominating the field of science. Evidence-based 
practice is defined as “the conscientious and judicious use of current best evidence in 
conjunction with clinical expertise and patient values to guide health care decisions” (Titler, 
2008, para. 3).  In 1992, only two journal articles mentioned the phrase evidence-based 
medicine; however just five years later, that number rose to over 1000. In a very short period of 
time, evidence-based medicine had evolved to become synonymous with the practices that 
encompassed the medical field (Sackett, 1996). With evidence-based medicine came a decline in 
qualitative research and a shift towards quantitative research. This shift changed the focus from 
primarily exploratory research to a type of research that involves systematic empirical 
investigation through the use of statistics, mathematics, and computational techniques 
(DeFranzo, 2011). With the introduction of computers and online databases came an increase in 
quantitative research and the use of statistics, which allowed for evidence-based medicine to 
grow exponentially in the early 1990s (Zimerman, 2013).  
 The push for evidence-based practices (EBP) in all fields - not just specifically in 
medicine - has directly led to the proliferation of both research journals and journal articles. In 
2012, there were approximately 28,100 active scholarly peer-reviewed journals publishing 1.8 to 
1.9 million articles a year, and that number continues to grow (Rallison, 2015). The United 
States National Library of Medicine’s premier bibliographic database, MEDLINE, shows 
statistics for the number of citations by year of publication. The total number of citations in the 
United States have almost quadrupled since 1970, from 64,161 to 278,341 in 2016 (National 
Institutes of Health [NIH], 2017). This exponential growth of scientific papers makes it 
increasingly more difficult for researchers and medical professionals to keep track of all that is 
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relevant to their fields and has created a growing concern about both the quality and quantity of 
the research being published.  
 The aforementioned concerns, which were sparked by the sheer number of published 
research, led to a multifield investigation regarding the reproducibility of published scientific 
literature. Initial questions were raised following a few landmark studies that did not hold up to 
replication by scientists in the field. In 2015, Brian Nosek, a social psychologist at the University 
of Virginia, and the head of the Center for Open Science set out with a group of researchers to 
conduct the biggest replication study of its kind (Baker, 2015). Nosek selected 100 original 
papers from three leading psychology journals to see if he and his research team could reach 
similar conclusions. The results were concerning: two-thirds of the replication results were so 
weak that they did not reach statistical significance (Open Science Collaboration, 2015). John 
Ioannidis, an epidemiologist and highly cited author of Why Most Published Research Findings 
are False, claimed that the true replication-failure rate could likely exceed 80%, since Brian 
Nosek’s Reproducibility Project targeted only highly acclaimed journals (Baker, 2015). The 
results of this study opened up a conversation that spans much further than the field of 
psychology and reaches deep into every field of research.  
The reproducibility crisis could be responsible, in part, for some of the conflicting 
headlines appearing in health-related news. Headlines often contain mixed information in the 
field of nutritional research. Articles have touted that a glass of red wine can help prevent cancer, 
chocolate can help with concentration, and even that coffee shows signs of cancer-fighting 
agents. However, the following week, there is yet another headline stating just the opposite. 
Therefore, it leaves the public wondering what evidence they should and should not accept. A 
quick Google search about red wine and the following results read: “red wine is bad for you, says 
Running Head: REPRODUCIBILITY CRISIS 4 
experts,” or “an extra glass of wine a day will shorten your life by 30 minutes,” followed by, 
“mounting evidence shows red wine antioxidants kill cancer.”  Schoenfeld and Ioannidis (2013) 
found that most food ingredients they studied (72%) were associated with both cancer risks and 
benefits. These false articles often influence dietary guidelines, are used to help shape public 
health policy, and influences individuals to change their lifestyle habits. With all of this mixed 
information available, it is challenging to make definitive conclusions often needed for evidence-
based practice.  
A further examination of the health field revealed numerous alarming discrepancies in 
biomedical research, which potentially affects new drug development and clinical treatments. 
According to Glenn Begley, the former head of oncology research at Amgen, "the ability to 
translate cancer research into successful clinical application has historically been very low 
especially in the field of oncology" (Begley & Ellis, 2012, para. 2). The quality of published 
preclinical data is one of the most significant contributions to the failure in oncology trials 
(Begley & Ellis, 2012). Over the years, the lack of quality data became more evident and led 
Begley and Ellis (2012) to conduct a reproduction study on 53 landmark papers. Begley and Ellis 
(2012) brought in the original researchers to help control for technical differences in research; 
however, the results showed that only six of the 53 (11%) were able to reproduce their own 
results. Begley is not the only one to come to this shocking conclusion. The German drug 
company Bayer reported that only 25% of published preclinical studies could be validated to 
allow the projects to continue (Begley & Ellis, 2012). This inability of the biomedical industry 
and clinical trials to validate the majority of results points to the existence of a systematic 
problem in the field that could potentially affect both the safety and effectiveness of clinical 
treatments and drugs on the market today.  
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The aforementioned concerns became even more evident when the present editor-in-chief 
of one of the most prestigious journals The Lancet, publicly stated, “much of the scientific 
literature, perhaps half, may simply be untrue” (Horton, 2015, para. 2). This quote is troubling 
given that these studies are being used to develop drugs and vaccines, as well as help to train 
medical staff and educate medical students (Walia, 2015). Dr. Marcia Angell, a physician and 
past editor of the prestigious New England Medical Journal stated,  
it is simply no longer possible to believe much of the clinical research that is published, 
or to rely on the judgement of trusted physicians or authoritative medical guidelines. I 
take no pleasure in this conclusion, which I reached slowly and reluctantly over my two 
decades as an editor of the New England Medical Journal (Walia, 2015, para. 3)  
These bold testimonies from highly respected individuals have brought these issues to the 
forefront of research journals and solidified the need for vast change in many aspects of 
scientific research.  
The lack of reproducibility hinders progress and threatens the reputation of science as a 
whole. In biomedical research, small changes in conditions or natural variability in biological 
systems can cause a study to be irreproducible. However, the scale by which studies are unable 
to be replicated is concerning and has an effect on the translation of studies into clinical 
practices, not to mention the wasting of valuable resources and tax dollars. As this issue came to 
the forefront, it became clear that scientists needed to come together to address this topic and 
formulate possible solutions. In 2015, the Academy of Medical Science, Wellcome Trust, 
Medical Research Council and Biotechnology, and Biological Sciences Council (BBSRC) held a 
symposium surrounding the issue of reproducibility in their fields in hopes to find causes and 
solutions and work to regain the public's trust in scientific research. The overall causes discussed 
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in this symposium and other literature surrounding this topic include statistical error, culture 
surrounding research, funding corruption and bias, and lack of data sharing and transparency 
(Academy of Medical Sciences, 2015). 
Statistical Error  
Ioannidis (2005) explained how statistical error and lack of statistical knowledge 
contributes to much of the non-reproducible scientific literature. The high rate of non-replication 
in research can be attributed to the convenient strategy of using P-values as the main conclusive 
measure of statistical significance. Statistical significance is one the most influential metrics in 
determining if a study is published in a scientific research journal (Ioannidis, 2005). In order for 
a result to be statistically significant in most fields of science, the p-value must fall below 0.05. If 
this is the case, by definition, scientists can declare their result statistically significant (Resnick, 
2017). The concept of statistical significance and p-values can be a hard to grasp, even for some 
scientists conducting research. To fully understand the impact that statistical error has on the 
reproducibility crisis, a brief explanation is necessary.  
To begin, on the one hand, the experimental or alternative hypothesis is one that states 
there is a statistically significant relationship between two variables (Gonzalez, 2019). On the 
other hand, the null hypothesis is essentially the devil's advocate argument (Resnick, 2017). The 
null hypothesis states that there is no difference between the two variables, and this is what the 
researcher is trying to prove wrong in order to accept the experimental hypothesis and draw 
conclusions (Gonzalez, 2019).  For example, rejecting the null helps researchers to understand 
the rarity of their results, and allows them to draw the conclusion that their alternative hypothesis 
could be true. In other words, the p-value helps to quantify the rareness of the results. If the 
researcher has a low p-value, it means that the data would rarely occur just by chance alone 
Running Head: REPRODUCIBILITY CRISIS 7 
(Resnick, 2017). However, it is important to note that researchers cannot rule out the null 
hypothesis indefinitely, which is the reason a threshold of 0.05 is set in place (Harris, 2017).  
A significant area of confusion lies in the meaning of getting a p-value of less than 0.05. 
The biggest misconception is that a P<0.05 means that there is a 95 percent chance that the 
finding is correct, and a five percent chance that it is wrong (Harris, 2017). Instead, achieving a 
P<0.05 means that if one assumes the null hypothesis is true and the experiment was conducted 
100 times, one would see the same results only five times (Resnick, 2017). There is a vast 
difference between the two definitions, and that is what often leads to the inflated trust placed in 
this value. Johnson (2013) proved this misconception wrong through advanced statistical 
techniques. There is a 25 to 30 percent chance that the null hypothesis is still true when the p-
value is 0.05 (Johnson, 2013). This percentage is a very big difference from the five percent that 
many people, including some researchers, believe to be the truth.    
 P-values were not originally designed to be the end all be all for statistical significance. 
Ronald Fisher, who was the first influence on the idea of p-values, emphasized that experiments 
should be performed many times to see if the results hold up and the p-value remains below the 
threshold (Harris, 2017). Scientists of today have not held on to this advice and have instead 
begun to abuse the use of the p-value to prove their data to be true. Most studies just barely reach 
a p-value of 0.05, and this is often because studies are designed from the start to reach that exact 
mark. Consequently, p-hacking is being used by many researchers to reach statistical 
significance and get their findings published.  
Uri Simonsohn, an economist at the University of Pennsylvania, became concerned with 
the growing number of findings that did not seem plausible in his field (Harris, 2017). 
Simonsohn and his colleagues set out to see how easy it would be to show that a finding was 
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true, when in fact it was not, and the results were concerning. Interestingly, it became clear how 
easy it is for scientists to look at their data and pull out bits that support their hypothesis and 
throw away ones that do not. Of particular concern part is that researchers can watch their data as 
they are being generated and the moment they reach statistical significance, they can stop the 
tests and declare their findings. This practice is extremely concerning because researchers are 
ignoring the fact that more data could result in a different outcome, but they are choosing to 
ignore that data in order to declare statistical significance (Harris, 2017). This process is called p-
hacking, and it is plaguing the research field. 
Brian Wansink, a researcher at Cornell University's Food and Brand Lab, is an example 
of a researcher who found himself in the spotlight due to statistical discrepancies in his research 
of which he claims to have not been aware of (Bartlett, 2017). Four papers that Wansink was co-
author of were found to contain not just one or two statistical discrepancies, but approximately 
150 inconsistencies. He was accused of recycling data from past experiments and was quoted 
telling a post-doctoral student that, "there's got to be something here we can salvage," when 
discussing their data (Bartlett, 2017, page or paragraph number of direct quote). This situation is 
a prime example of p-hacking, which shows that if one tampers with the data long enough, a 
finding may be revealed that looks significant, but in reality, is meaningless. A lot of people 
believe that researchers are often fooling themselves, and this was exactly the case for Brain 
Wansink. He said that he was unaware of the reproducibility crisis and the term p-hacking, until 
he found himself accused of such behavior (Bartlett, 2017). 
As if p-hacking was not enough of a problem in the field, another popular term and 
practice that has been contributing to a lot of the statistical error in research is HARKing. This 
term edifies the process of creating a hypothesis after the results are known (Harris, 2017). 
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Clearly, this process is opposite of the scientific method and is extremely problematic. Scientists 
are taking data and running multiple tests, which they then use to make a hypothesis for which 
they already see a promising result. This practice is stepping over the line from confirmatory 
research to exploratory research, which is not what statistical tests were designed to do. While 
most research of this kind begins with good intentions, it is clear that scientists are abusing the 
tools of statistical analysis, and the results are misleading and inappropriate (Harris, 2017). 
 To pose a solution to this problem, Johnson and other scientists, including Ioannidis, 
believe that more stringent standards for p-values should be met. Johnson suggested that a 
p<0.005 should be the standard in the field. In this case, researchers can be confident that there 
is, in fact, a 95 percent chance that their findings will remain statistically significant if the study 
is run again (Harris, 2017). In essence, scientists hope that with a lower p-value, less false 
positives will be present in the literature, and it will require scientists to develop better research 
designs, increase sample sizes, and improve statistical techniques. However, this proposal was 
not met with unanimous support. Some scientists worry that this requirement will slow down the 
process and impede young doctoral students with limited budgets (Resnick, 2017). Ioannidis 
admitted that, "statistical significance alone doesn’t convey much about the meaning, 
importance, clinical value, or the utility of research” (Resnick, 2017, page or paragraph number). 
However, Ioannidis purported that we live in a scientific culture that relies on p-values because 
of their quick and easy methods (Resnick, 2017).   
An alteration in the threshold for p-values is the first line of business before other 
problems in statistics can be addressed (Resnick, 2017). Supporters of lowering the p-value also 
agree that findings that reach a p-value of 0.05 should still be considered; however, they should 
be classified as suggestive. Findings that reach 0.005 should be classified as statistically 
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significant. Findings that are suggestive are still important in advancing science; however, they 
should require further testing, and they should elicit some caution among readers when they are 
listed as breakthroughs in the scientific headlines (Resnick, 2017).  
 At the root of statistical error in science is the lack of a solid foundation of statistics 
among scientists and medical professionals. Casadevall believed that the reproducibility crisis 
begins in the way we train our scientists (Harris, 2017). According to Leonard Freedman’s 
estimate, one in four irreproducible results in biomedicine are a result of analytical error. He 
believes that a significant reason for analytical error is the lack of statistics training among 
biomedical researchers. With the move towards evidence-based practice, and developments in 
technology, big data sets are the reality. Biology, which once was largely a descriptive science, is 
now dealing with large data sets and complicated analytical techniques (Harris, 2017). 
Consequently, it is clear that the education system needs to catch up and integrate more math and 
science courses into their curriculum.  
Casadevall and Fang (2016) believed that an obvious step in strengthening rigor in 
scientific research is through proper training in experimental design, statistics, error analysis, 
logic, and ethics. However, currently, even statistics is not always a requirement in graduate 
school curriculums. Furthermore, statistics is not always a prerequisite course for medical 
school, and once in medical school, statistics education is minimal (Kaplan, 2019). This lack of 
in-depth statistics training is problematic, particularly considering the fact that medical 
professionals are expected to understand and educate their patients on the literature in the field. 
Therefore, it is necessary that medical professionals and researchers have the statistics 
knowledge that allows them to be critical about what they read in the literature in order to avoid 
blindly trusting the research. 
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Culture Surrounding Research  
 Through adjusting the scope and looking at the big picture of the reproducibility crisis, it 
becomes clear that there is a more overarching issue at hand, and that is the culture surrounding 
science as a whole. To begin, job security in the field of research is extremely scarce. A study 
conducted by the National Institutes of Health, using data from 2008, showed that only 21 
percent of post-docs will receive a tenure-track job (Harris, 2017). While there may be variation 
in this data since 2008, it is clear that this shortage of spots results in a highly competitive 
environment in the field of research. The large pool of researchers and shortage of job 
opportunities forces hiring committees to base their decisions on researchers publishing history 
and, more importantly, on the impact factor of the journals in which researchers were published. 
An impact factor is essentially a score allotted to a journal based on how often its papers are 
cited in the literature (Schekman, 2013). The impact factor is critical because scientists rely on 
getting published in journals with high impact factors in order to receive subsequent grants, 
promotions, tenure, and to boost their reputation in the field (Resnick, 2017).  
The focus on publishing is also the reality in academia. University professors rely on 
publishing, particularly in high impact factor journals, to boost their chances of receiving tenure, 
getting promoted, and receiving grant money (Harris, 2017). This practice has caused a 
dangerous mentality that is referred to as publish or perish. Resnick (2017) recounted a young 
scientist who shared, "I feel torn between asking questions that I know will lead to statistical 
significance and asking questions that matter” (p. 12). In order to keep funding and to progress 
their careers, researchers are stuck with the decision to choose projects that will likely succeed 
and produce positive results, rather than to ask difficult research questions that may result in 
greater progress. This duality exemplifies that the true root of the problem is not strictly 
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statistical error and the reliance on statistical significance, but instead may be the institution of 
science, which has incentivized the behaviors to allow it to fester in the field of research 
(Resnick, 2017).   
 Schekman (2013 believed one of the biggest reasons that the culture of science is to 
blame for the reproducibility crisis is because "people know what it takes to get their paper into 
one of these journals, and they will bend the truth to make it fit because their career is on the 
line” (Harris, 2017, p. 177). This pressure to publish specifically in journals with high impact 
factors lures scientists to cut corners and tempts them to focus on data that may help their 
research look better (Schekman, 2013). Rather than incentivizing quality research designs and 
proper statistical techniques, journals are creating a culture that incentivizes being first, even if 
that means being sloppy and cutting corners to get published (Harris, 2017). Journals with high 
impact factors know that highly cited research is usually flashy and eye-catching. Therefore, that 
is what journals tend to publish, even if it means it is wrong and will not stand the test of time. 
Therefore, in order to get published, researchers are having to adjust to that standard and choose 
research that makes bold claims, rather than encouraging replication studies, or meta-analyses, 
which have an even greater impact on the field (Schekman, 2013).  
 The problem is that journals put too much weight on single studies rather than 
incentivizing replication studies, meta-analysis, and even the publication of negative results. A 
study conducted by PLOS assembled a database of studies in biomedical science which included 
the initial study, follow-up studies, and meta-studies (Resnick, 2017). The Dow Jones Factiva 
newspaper was then searched to see how each type of study was covered. Ultimately, initial 
studies were five times more likely to be covered than follow-up studies, and meta-analysis 
reviews were rarely covered at all. The most concerning findings were that out of 1,475 
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newspaper articles, only 75 of the articles reported null findings (Resnick, 2017). Null findings 
can be just as impactful in the field of science; however, not only are they rarely reported, they 
are discouraged. This hesitancy is creating a culture that only incentivizes positive study results, 
and researchers' careers are dependent upon those findings. If a researcher has worked on a study 
for years and he/she comes to realize the study is not holding up as originally planned, the 
researcher is forced to either accept that time and money has been wasted, or it may lure the 
researcher to tweak his/her data to still get published. This practice is perpetuating the publish or 
perish mentality, and the institution of science needs to be better at rewarding failure (Resnick, 
2017). Scientists should not fear the idea of failure, but instead should welcome it because failed 
studies can be just as impactful to advancing science. However, this change in mentality can only 
occur if the incentives for scientists are altered as well.  
 Scheckman (2013) believed one solution to the problem of incentives is a new breed of 
open-access journals. Allowing free access eliminates the need for promoting expensive 
subscriptions. Furthermore, open access journals should accept papers that meet quality 
standards and can be edited by working scientists who can assess the worth of the papers without 
regard for the number of citations as a measure of success. A current example of this is eLife, an 
open access journal funded by the Wellcome Trust, the Howard Hughes Medical Institute, and 
the Max Planck Society (Scheckman, 2013). eLife is a real-world example of a journal that is 
publishing credible, world-class science in a more accessible manner. Along with this change, 
however, funders and universities must also adjust. Grant funders and academia must begin to 
change their standards and stop basing positions and grants on the number of published papers, 
but instead base success on the quality of science (Scheckman, 2013). This shift in mindset 
Running Head: REPRODUCIBILITY CRISIS 14 
would help to change the incentives and alleviate the pressure to publish just for the sake of 
publishing. 
Funding Corruption and Bias  
While fraud in science is not a huge contributing factor to the reproducibility crisis, it 
does play a role in the culture of research. The federal Office of Research Integrity cites cases of 
scientific misconduct annually, such as the one at Rowan University School of Osteopathic 
Medicine, where an associate professor intentionally fabricated data that led to eight published 
papers and grants from the National Institute of Health. These stories rarely make the news, the 
researchers are rarely punished, and retraction statements are vague (Harris, 2017). Casadevall 
and Fang (2012) investigated published retractions and found that 70 percent of the retractions 
they found were due to misconduct rather than simply error. Retractions were also more common 
in high profile journals, which may be due, in part, to the need to publish in those journals to 
advance researchers’ careers (Casadevall & Fang, 2012).  
Fraud in the context of corporate influence over research has led to a great deal of the 
bias and mistrust in the field. Research is often done at the wishes of companies that, in turn, 
have a large financial stake in the results (Ioannidis, 2011). This financial stake is especially true 
of the pharmaceutical industry, which has essentially bought out the medical profession. A prime 
example occurred in 1999, when a new leading drug called Avandia came onto the market to 
help treat diabetes (Whoriskey, 2012). Follow-up studies resulted in some alarming conclusions 
that showed an increased risk of heart attacks from taking Avandia. As a result, the drug 
company GlaxoSmithKline was forced to release their original data from the study.  Ultimately, 
it was determined that important data were omitted from the original analysis, and the company 
was accused of knowing about the increased risk of heart disease all along. Upon further 
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investigation, the financial connection between the drug maker and the researchers was alarming. 
The study was funded by GlaxoSmithKline, and the 11 authors received monetary compensation 
from the drug company. While it is not clear whether the financial association between the drug 
company and the research led to the report and data being altered, what is clear is that any form 
of financial connection increases bias (Whoriskey, 2012).  
While retractions are common, the public is rarely informed when initial studies are 
disconfirmed (Resnick, 2017). Allison, a researcher at the University of Alabama, Birmingham, 
found out how difficult it can be to get retractions published, so that the public can be informed 
of disconfirmed studies (Harris, 2017). When Allison and his colleagues sent letters to journals 
pointing out clear mistakes, they were shocked when they were asked to pay up to $2,000 dollars 
to publish these letters and set the record straight on other researchers' studies (Harris, 2017). 
One of the reasons for this practice is that scientists hate to admit mistakes, and journals who 
publish them are the same. This reluctance to admit to mistakes is partly due to pride, but mostly 
due to the fact that error can put a black-mark on one’s record and impede a scientist's ability to 
advance his/her career, secure tenure, and receive subsequent funding (Harris, 2017). This lack 
of accountability is further evidence that a more fault-free system of admitting mistakes is 
necessary in the field. The culture of science needs to be altered to allow researchers to not feel 
as though their career is on the line if their study fails. This renewed culture would help foster a 
better research environment that could potentially reduce sloppy research and questionable 
practices in the field.    
Lack of Data Sharing and Transparency  
One overarching and powerful solution to reducing poor quality research designs, p-
hacking, HARKING, and outright fraud in the field of research is to increase transparency of 
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research designs and data. One of the reasons statistical error and fraud are not often caught is 
because most published methods are either vague or deliberately kept secrete (Resnick, 2017). 
Good quality research that the public can trust requires disclosure and openness, and the best 
way to boost the reproducibility of studies is through pre-registration of research. This practice is 
one of the easiest ways to ensure that scientists are not able to fraudulently hand-pick data, 
change their hypothesis, or alter any part of their study (Walia, 2015). Nosek, who completed the 
aforementioned replication study in the field of psychology, created a platform that serves to 
accomplish this goal of transparency, called the Open Science Framework (Harris, 2017). OSF is 
acts as a data repository that invites scientists to register their hypothesis in advance to ensure 
that their results were, indeed, confirmatory (Harris, 2017). OSF provides scientists a platform 
for organizing their entire experiment through an interface where they can store all aspects of 
their research in a safe and open manner (Center for Open Science, n.d.). The biggest barrier of 
convincing scientists to switch over to this program is at the moment, there is not much of an 
incentive to share data, especially prior to the experiment being completed. With the competitive 
nature of research, it is difficult to convince scientists to share their data, given the chance that 
another researcher could take on their research and potentially get published first. This lack of 
data sharing reiterates the idea of the culture of science and the need to advance one’s career 
over all else. While open data and methods do increase the risk of other scientists using one’s 
data, open data also helps detect error prior to publishing, and allows for quicker progress of 
science through collaboration. The OSF program, in turn, helps to increase the trust that the 
researchers, medical professionals, and the public has in published scientific literature.  
How to Avoid Poor Research 
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Following this discussion of the reproducibility crisis, the question remains about what 
medical professionals can do to best spot poor research and avoid basing clinical procedures or 
medical advice on false research. Ultimately, it is important that health care professionals are 
educated on the reproducibility issues facing scientific research, so that they can be more critical 
when it comes to reading the literature. Begley (2013) explained the best ways to recognize poor 
data in pre-clinical papers that will likely lead to nonreplicable studies that cannot be fully 
trusted. Begley (2013) suggested that every reader evaluating a research paper should ask the 
following six question: "were experiments being performed blind, were basic experiments 
repeated, were all results presented, were there positive and negative controls, were reagents 
validated, and were statistical tests appropriate” (Begley, 2013, p. 434).  
Studies that are performed unblinded are inherently more biased in nature and should be 
read with caution. Replication of experiments throughout a study can be expensive and time-
consuming; however, they provide evidence for the validity and reliability of a study. A study 
that does not disclose all data and results is lacking transparency and the ability for future 
researchers to validate their work is not possible. In addition, it is imperative that clear and 
detailed methods are presented in the literature, so that the study can be replicated by future 
researchers. Moreover, it is also important to note whether studies use positive and negative 
controls in their experiment and whether they disclose data on both (Begley, 2013). Additionally, 
it is critical that studies have validated their reagents by making sure they test their materials 
prior to the experiment. For instance, there is a lot of research that shows nonreplicable studies 
that were due to contaminated cell lines, which were believed to contain certain cancer cells, but 
turned out to be different cancer cells (Harris, 2017).  
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The final and potentially most important question to ask is regarding the researcher's 
statistical analysis. Appropriate statistical techniques should be decided before the onset of a 
study. Appropriate tests depend on many factors, including the type of research question being 
asked, the type of data collected, the number of groups in the study, and the number of data sets 
(Nayak & Hazra, 2011). To ensure that proper analysis and conclusions can be made, it is 
imperative that appropriate tests are performed.  
With the sheer number of new studies published every week, it may be difficult for 
medical professional to fully dive deep into the methods and research design of every research 
study they come across. Therefore, there are quicker ways to spot questionable research. To 
begin, if a study is simplistic, universal, or definitive, it is a good idea to proceed with caution 
while reading. Any finding in the literature that is supported by only a single study should be 
further backed up by subsequent research, and until then should be considered questionable. 
Studies claiming to be groundbreaking or are being pushed by people or organizations that have 
a financial stake in the studies’ success, should be considered biased at best (Freedman, 2010). 
Finally, medical professionals should be leery of small studies with small effect sizes. Small 
studies are more likely to present false positives. and having a small effect size can result in data 
that is statistically significant. However, with an effect size so weak the results could be deemed 
meaningless (Oxenham, 2015).  
Conclusion 
With a reproducibility crisis of this scale affecting the field of science, it is often difficult 
to see clear steps that can be made towards a more trustworthy and rigorous research 
environment. Knowing the core causes of the reproducibility crisis, which include statistical 
error, lack of data transparency, fraud and corporate influence, and the culture of science and 
Running Head: REPRODUCIBILITY CRISIS 19 
research, helps scientists to better understand where changes can be made. To reiterate, 
adjustments in the p-value can have tremendous effects on the value of statistical significance 
and will result in far less false positives in the literature. Starting at the foundation of education, 
statistics courses need to be better implemented into curricula to give all professionals a stronger 
knowledge base to use when conducting research and evaluating studies. Altering incentives in 
the field can help to alleviate the culture surrounding research that promotes the publish or perish 
mentality. With changes in this area, a system can be created that is more forgiving of failure and 
promotes publishing of null findings, meta analyses, and replication studies. In addition, 
promoting more open access journals, and platforms such as the Open Science Framework, will 
allow for greater transparency in data, methods, and research designs. Finally, as a medical 
professional, researcher, or lay person, it is important to be critical and to address every study 
with the aforementioned questions to assure that the individual is reading and trusting studies 
with rigorous study designs, correct statistical analyses, and ethical research practices.   
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